Table 3.
Summary of logistic regression analysis predicting acute side effects
| Variable | B | SE | OR | 95% CI | Wald statistic | p |
|---|---|---|---|---|---|---|
| First dose | ||||||
| Sex | - 0.99 | 0.29 | 0.37 | [0.21, 0.65] | 11.99 | 0.00 |
| Alive/deceased | - 0.46 | 0.42 | 0.63 | [0.28, 1.44] | 1.21 | 0.27 |
| Breast cancer vs Melanoma/skin cancer | 22.08 | 21971.91 | 3.865E + 9 | [0.00,.] | 0.00 | 0.99 |
| Breast cancer vs Lung cancer | 0.58 | 1.56 | 1.78 | [0.08, 37.49] | 0.14 | 0.71 |
| Breast cancer vs Other | 0.44 | 1.33 | 1.55 | [0.11, 21.14] | 0.11 | 0.74 |
| NED/metastatic | 0.55 | 0.24 | 1.72 | [1.07, 2.78] | 5.03 | 0.03 |
| No/Yes | - 0.25 | 0.38 | 0.78 | [0.37, 1.62] | 0.44 | 0.51 |
| Chemotherapy vs Follow-up | - 0.14 | 0.29 | 0.87 | [0.49, 1.55] | 0.22 | 0.64 |
| Chemotherapy vs Other | 0.56 | 0.41 | 1.75 | [0.79, 3.89] | 1.88 | 0.17 |
| Type of vaccine | 2.10 | 1.44 | 8.17 | [3.70, 18.05] | 27.03 | 0.00 |
| Second dose | ||||||
| Sex | - 0.02 | 0.25 | 0.98 | [0.59, 1.61] | 0.00 | 0.94 |
| Alive/deceased | 1.50 | 0.53 | 4.47 | [1.59, 12.54] | 8.08 | 0.00 |
| Breast cancer vs Melanoma/skin cancer | 18.44 | 11436.68 | 102091047 | [0.00,.] | 0.00 | 0.99 |
| Breast cancer vs Lung cancer | 17.13 | 11436.68 | 27570621.8 | [0.00,.] | 0.00 | 0.99 |
| Breast cancer vs Other | 17.85 | 11436.68 | 56432713.6 | [0.00,.] | 0.00 | 0.99 |
| NED/metastatic | - 0.31 | 0.23 | 0.73 | [0.47, 1.14] | 1.91 | 0.17 |
| No/Yes | 0.07 | 0.36 | 1.07 | [0.53, 2.17] | 0.04 | 0.84 |
| Chemotherapy vs Follow-up | 0.11 | 0.28 | 1.11 | [0.65, 1.91] | 0.15 | 0.70 |
| Chemotherapy vs Other | 0.25 | 0.39 | 1.28 | [0.60, 2.75] | 0.40 | 0.53 |
| Type of vaccine | - 0.25 | 0.25 | 0.78 | [0.46, 1.28] | 0.98 | 0.32 |
| Third dose | ||||||
| Sex | - 0.56 | 0.34 | 0.57 | [0.30, 1.11] | 2.72 | 0.10 |
| Alive/Deceased | 21.97 | 40192.73 | 3.477E + 9 | [0.00,.] | 0.00 | 1 |
| Breast cancer vs Melanoma/skin cancer | 44.75 | 49217.93 | 2.720E + 19 | [0.00,.] | 0.00 | 0.99 |
| Breast cancer vs Lung cancer | 22.73 | 28406.74 | 7.437E + 9 | [0.00,.] | 0.00 | 0.99 |
| Breast cancer vs Other | 22.48 | 28406.74 | 5.788E + 9 | [0.00,.] | 0.00 | 0.99 |
| NED/metastatic | 0.21 | 0.29 | 1.23 | [0.69, 2.19] | 0.50 | 0.48 |
| No/Yes | - 1.25 | 0.99 | 0.29 | [0.04, 2.01] | 1.58 | 0.21 |
| Chemotherapy vs Follow-up | 0.22 | 0.37 | 1.24 | [0.61, 2.54] | 0.35 | 0.56 |
| Chemotherapy vs Other | 1.46 | 1.08 | 4.33 | [0.52, 35.72] | 1.85 | 0.17 |
| Type of vaccine | 0.65 | 0.40 | 1.91 | [0.88, 4.16] | 2.64 | 0.10 |
Note: ∗ Simple contrast method with first category (breast cancer) as reference. ∗∗ Cancer Type: breast cancer, gastroenteric cancer, melanoma, lung cancer, genitourinary cancer, gynecological cancer, skin cancer, prostatic cancer, glioblastoma, other type of cancer.